ENLON-PLUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enlon-plus, and what generic alternatives are available?
Enlon-plus is a drug marketed by Mylan and Mylan Institutional and is included in two NDAs.
The generic ingredient in ENLON-PLUS is atropine sulfate; edrophonium chloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENLON-PLUS?
- What are the global sales for ENLON-PLUS?
- What is Average Wholesale Price for ENLON-PLUS?
Summary for ENLON-PLUS
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 3,418 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ENLON-PLUS at DailyMed |
![ENLON-PLUS drug patent expirations Drug patent expirations by year for ENLON-PLUS](/p/graph/s/t/ENLON-PLUS-patent-expirations.png)
US Patents and Regulatory Information for ENLON-PLUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENLON-PLUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ENLON-PLUS
See the table below for patents covering ENLON-PLUS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1200500 | COMPOSE D'EDROPHONIUM AVEC DE L'ATROPINE ET USAGES THERAPEUTIQUES (EDROPHONIUM-ATROPINE COMPOSITION AND THERAPEUTIC USES THEREOF) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |